Home › Funds › Bain Capital Life Sciences Investors, LLC › HTFL

Bain Capital Life Sciences Investors, LLC position in HTFL

HEARTFLOW INC · Health Care

Bain Capital Life Sciences Investors, LLC reported holding 4,448,158 shares of HTFL (HEARTFLOW INC) in its Q3 2026 13F filing — a position valued at US$221.3M, representing 15.23% of its reported portfolio and ranking #2 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed HTFL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

Latest position (Q3 2026)4.45M sh
Reported value held$221.30M
Portfolio Weight15.23%
First reportedQ3 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Bain Capital Life Sciences Investors, LLC's HTFL position evolved

Bain Capital Life Sciences Investors, LLC first disclosed a stake in HTFL in Q3 2025 at 12,448,158 shares (US$419.0M). Across 5 filings, Bain Capital Life Sciences Investors, LLC increased the stake 0 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 4,448,158 shares valued at US$221.3M — a reduction of -4,000,000 shares quarter over quarter.. Notable position changes include a 47% trim in Q3 2026 (shares fell 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 12.45M $419.00M New
Q4 2025 12.45M $362.86M Hold
Q1 2026 10.45M $254.20M Reduce
Q2 2026 8.45M $247.87M Reduce
Q3 2026 4.45M $221.30M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HTFL and 13F data

HTFL (HEARTFLOW INC) is a Health Care company. 99 other funds we track also report a position in HTFL — the largest reported positions include BAMCO INC /NY/ (US$124.9M), SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC (US$72.2M), NZS Capital, LLC (US$33.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HTFL

All HTFL fund holders →

FAQ

How long has Bain Capital Life Sciences Investors, LLC held HTFL?

Bain Capital Life Sciences Investors, LLC has disclosed HTFL holdings in 5 of the last 5 reported quarters, going back to Q3 2025.

What is Bain Capital Life Sciences Investors, LLC's current position in HTFL?

As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 4.45M shares of HTFL (HEARTFLOW INC), valued at $221.30M, representing 15.23% of its reported portfolio and ranking #2.

Has Bain Capital Life Sciences Investors, LLC been buying or selling HTFL?

In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC reduced its position in HTFL.

Which other funds hold HTFL?

Other major institutional holders of HTFL include BAMCO INC /NY/, SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC, NZS Capital, LLC, among 99 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.